Palleon Pharma

Developer of novel drugs for treating the innate immune system

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups24 employees language palleonpharma.com

Registered entities

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace dormant. Cited 13 times.

YearFilings
20171

Social engagement

Social engagement: 7.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include SR One, Pfizer Venture Investments, Vertex Ventures HC, Takeda Ventures.

Investor typeCountShare
Venture capital450%
Other / undisclosed450%

Recent activity

8 May 2026
Product launch
E-688
2 Apr 2026
Event
AACR Annual Meeting
Coming soon